XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.21.2

Restructuring and Impairment Charges Restructuring and Impairment Charges (Notes) | 8 Months Ended
--- | ---
Sep. 04, 2021
Restructuring and Related Activities [Abstract] |
Restructuring, Impairment, and Other Activities Disclosure [Text Block] | Restructuring and Impairment Charges 2019 Multi-Year Productivity Plan We publicly announced a multi-year productivity plan on February 15, 2019 (2019 Productivity Plan) that will leverage new technology and business models to further simplify, harmonize and automate processes; re-engineer our go-to-market and information systems, including deploying the right automation for each market; and simplify our organization and optimize our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan to date, we expanded and extended the plan through the end of 2026 to take advantage of additional opportunities within the initiatives described above. We now expect to incur pre-tax charges of approximately $3.15 billion, including cash expenditures of approximately $2.4 billion, as compared to our previous estimate of pre-tax charges of approximately $2.5 billion, which included cash expenditures of approximately $1.6 billion. These pre-tax charges are expected to consist of approximately 65% of severance and other employee-related costs, 10% for asset impairments (all non-cash) resulting from plant closures and related actions, and 25% for other costs associated with the implementation of our initiatives. The total expected plan pre-tax charges are expected to be incurred by division approximately as follows:
| FLNA |  | QFNA |  | PBNA |  | LatAm |  | Europe |  | AMESA |  | APAC |  | Corporate
Expected pre-tax charges | 15 | % |  | 1 | % |  | 25 | % |  | 10 | % |  | 25 | % |  | 6 | % |  | 3 | % |  | 15 | %
A summary of our 2019 Productivity Plan charges is as follows:
| 12 Weeks Ended |  | 36 Weeks Ended
| 9/4/2021 |  | 9/5/2020 |  | 9/4/2021 |  | 9/5/2020
Cost of sales | $ | 9 |  |  | $ | 1 |  |  | $ | 13 |  |  | $ | 4 |
Selling, general and administrative expenses | 42 |  |  | 59 |  |  | 110 |  |  | 112 |
Other pension and retiree medical benefits expense | 1 |  |  | 1 |  |  | 6 |  |  | 8 |
Total restructuring and impairment charges | $ | 52 |  |  | $ | 61 |  |  | $ | 129 |  |  | $ | 124 |
After-tax amount | $ | 45 |  |  | $ | 48 |  |  | $ | 109 |  |  | $ | 101 |
Net income attributable to PepsiCo per common share | $ | (0.03) |  |  | $ | (0.03) |  |  | $ | (0.08) |  |  | $ | (0.07) |
| 12 Weeks Ended |  | 36 Weeks Ended |  | Plan to Date
| 9/4/2021 |  | 9/5/2020 |  | 9/4/2021 |  | 9/5/2020 |  | through 9/4/2021
FLNA | $ | 2 |  |  | $ | 2 |  |  | $ | 20 |  |  | $ | 9 |  |  | $ | 156 |
QFNA | 1 |  |  | — |  |  | 1 |  |  | 1 |  |  | 13 |
PBNA | 3 |  |  | 29 |  |  | 8 |  |  | 32 |  |  | 146 |
LatAm | 14 |  |  | 5 |  |  | 22 |  |  | 14 |  |  | 124 |
Europe | 20 |  |  | 13 |  |  | 46 |  |  | 29 |  |  | 199 |
AMESA | 5 |  |  | 2 |  |  | 9 |  |  | 9 |  |  | 64 |
APAC | 1 |  |  | 1 |  |  | 2 |  |  | 4 |  |  | 56 |
Corporate | 5 |  |  | 8 |  |  | 15 |  |  | 18 |  |  | 105 |
| 51 |  |  | 60 |  |  | 123 |  |  | 116 |  |  | 863 |
Other pension and retiree medical benefits expense | 1 |  |  | 1 |  |  | 6 |  |  | 8 |  |  | 63 |
Total | $ | 52 |  |  | $ | 61 |  |  | $ | 129 |  |  | $ | 124 |  |  | $ | 926 |
| 12 Weeks Ended |  | 36 Weeks Ended |  | Plan to Date
| 9/4/2021 |  | 9/5/2020 |  | 9/4/2021 |  | 9/5/2020 |  | through 9/4/2021
Severance and other employee costs | $ | 28 |  |  | $ | 23 |  |  | $ | 77 |  |  | $ | 47 |  |  | $ | 521 |
Asset impairments | 3 |  |  | 15 |  |  | 4 |  |  | 20 |  |  | 129 |
Other costs | 21 |  |  | 23 |  |  | 48 |  |  | 57 |  |  | 276 |
Total | $ | 52 |  |  | $ | 61 |  |  | $ | 129 |  |  | $ | 124 |  |  | $ | 926 |
Severance and other employee costs primarily include severance and other termination benefits, as well as voluntary separation arrangements. Other costs primarily include costs associated with the implementation of our initiatives, including contract termination costs, consulting and other professional fees. A summary of our 2019 Productivity Plan activity for the 36 weeks ended September 4, 2021 is as follows:
| Severance and Other Employee Costs |  | Asset Impairments |  | Other Costs |  | Total
Liability as of December 26, 2020 | $ | 122 |  |  | $ | — |  |  | $ | 5 |  |  | $ | 127 |
2021 restructuring charges | 77 |  |  | 4 |  |  | 48 |  |  | 129 |
Cash payments (a) | (119) |  |  | — |  |  | (46) |  |  | (165) |
Non-cash charges and translation | (8) |  |  | (4) |  |  | (2) |  |  | (14) |
Liability as of September 4, 2021 | $ | 72 |  |  | $ | — |  |  | $ | 5 |  |  | $ | 77 |
(a)Excludes cash expenditures of $2 million reported in the cash flow statement in pension and retiree medical contributions. Substantially all of the restructuring accrual at September 4, 2021 is expected to be paid by the end of 2021. Other Productivity Initiatives There were no charges related to other productivity and efficiency initiatives outside the scope of the 2019 Productivity Plan. We regularly evaluate different productivity initiatives beyond the productivity plan and other initiatives described above.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration